Insights on operationalizing COVID-19 monoclonal antibody treatment
Social, not just biological factors, key in increased knee injuries among girls and women
26 March 2021Toxic metabolic encephalopathy worsens COVID-19 outcomes
26 March 2021Insights on operationalizing COVID-19 monoclonal antibody treatment
As evidence mounts supporting the use of monoclonal antibody treatment to reduce hospitalizations and deaths from COVID-19, UPMC and University of Pittsburgh School of Medicine physician-scientists are sharing the health system’s experience administering the life-saving medication.
